Overview
Jan Zeevaart practices practicing medicine in Potchefstroom, South Africa.
Their clinical expertise encompasses Prostate Cancer, Insulinoma, Bladder Cancer, and Neuroendocrine Tumor.
They are actively involved in clinical research, co-authoring 79 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Jan R. Zeevaart
Is Jan R. Zeevaart a top-rated expert for Prostate Cancer?
MediFind is an objective health platform that identifies experts based on real-world data. Jan R. Zeevaart is classified as an Experienced expert for Prostate Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Jan R. Zeevaart participate in research or clinical trials?
Yes. Jan R. Zeevaart has published 79 articles and abstracts on conditions like Prostate Cancer. You can view a list of Jan R. Zeevaart's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Bladder CancerZeevaart isExperienced. Learn about Bladder Cancer.
- InsulinomaZeevaart isExperienced. Learn about Insulinoma.
- Neuroendocrine TumorZeevaart isExperienced. Learn about Neuroendocrine Tumor.
- Prostate CancerZeevaart isExperienced. Learn about Prostate Cancer.